Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Breast 2Gynecologic 1CNS 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 765Gemcitabine 651Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 441Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 218pembrolizumab 206Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 181Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × ferumoxtran-10 × Gastrointestinal × Clear all
NCT02253602 2019-01-16

IMPROVE

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed
41 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02751606 2018-12-06

Nano MRI on 7 Tesla in Rectal and Breast Cancer

Radboud University Medical Center

Phase 3 Unknown
30 enrolled
BreastGastrointestinal

Breast Neoplasms, Rectal Neoplasms

NCT00920023 2017-07-25

Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)

Massachusetts General Hospital

Phase 4 Completed
35 enrolled 5 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡